AI Article Synopsis

  • Low anterior resection syndrome (LARS) is a functional disorder that often affects women after rectal surgery, specifically studied here in patients with advanced epithelial ovarian cancer (EOC).
  • A multi-center analysis of 125 female patients (56 with EOC and 69 with rectal cancer) found similar rates of LARS between the two groups post-surgery, with 30.4% reporting bowel dysfunction.
  • The study concludes that LARS is common but underreported in EOC patients, and its functional outcomes are comparable to those of female rectal cancer patients who did not undergo radiotherapy.

Article Abstract

Background: Low anterior resection syndrome (LARS) is a common functional disorder after low anterior resection impacting the quality of life. Data on LARS derives nearly exclusively from rectal cancer studies. Therefore, the study was designed to assess LARS in advanced epithelial ovarian cancer (EOC) patients, who underwent rectal resection and to compare it with a female rectal cancer cohort.

Material And Methods: A cross-sectional multi-centre analysis was performed on female patients suffering from either rectal or EOC who received a low anterior resection as part of their therapy regimen. None of the patients received pre- or postoperative radiotherapy. LARS was defined by using the validated LARS score and its severity was divided into "no", "minor" and "major LARS".

Results: In total, 125 female patients (44.8% (n = 56) EOC vs. 55.2% (n = 69) rectal cancer patients) met the final inclusion criteria and were retrospectively analyzed. Baseline characteristics were comparable between the groups. Median follow-up was 22 (IQR 12-56) months. In total, 30.4% (n = 38) of the patient group reported bowel dysfunction after surgery. Rates of LARS were not significantly different between EOC and rectal cancer patients (major LARS 16.1% (n = 9) vs. 15.9% (n = 11); minor LARS 17.9% (n = 10) vs. 11.6% (n = 8); p = 0.984). The time interval between surgery and final assessment had no impact on the postoperative bowel function (p = 0.820).

Conclusion: LARS is a frequent and highly underreported postoperative disorder in EOC patients who require cytoreductive surgery with rectal resection. The functional outcome is comparable to female patients with rectal cancer who underwent low anterior resection without receiving radiotherapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijsu.2020.04.019DOI Listing

Publication Analysis

Top Keywords

low anterior
20
anterior resection
20
rectal cancer
20
cancer patients
12
female patients
12
lars
10
patients
9
resection syndrome
8
syndrome lars
8
ovarian cancer
8

Similar Publications

Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome.

BMC Complement Med Ther

January 2025

Institute of Basic Medical Sciences of Xiyuan Hospital, Beijing Key Laboratory of Chinese Materia Pharmacology, China Academy of Chinese Medical Sciences, National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases, Beijing, China.

Objectives: This study intended to explore whether the protective effect safflower yellow injection (SYI) on myocardial ischemia-reperfusion (I/R) injury in rats mediated of the NLRP3 inflammasome signaling.

Methods: The I/R model was prepared by ligating the left anterior descending coronary artery for 45 min and then releasing the blood flow for 150 min. 96 male Wistar rats were randomly divided into sham group, I/R group, Hebeishuang group (HBS), SYI high-dose group (I/R + SYI-H), SYI medium-dose group (I/R + SYI-M) and SYI low-dose group (I/R + SYI-L).

View Article and Find Full Text PDF

Background: Older vervet monkeys are an excellent model for studying age-associated Aβ deposition; however, they have high proportions of low-affinity Aβ sites compared to human brains. Commonly used Aβ PET radiotracers are most useful in detecting high affinity Aβ fibrils. Measuring real-time levels of low affinity Aβ fibrils through PET provides critical information of early AD progression.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Imperial College London, London, UK.

Background: Alzheimer's disease and type 2 diabetes mellitus rank among the top ten leading global causes of death. The association between diabetes and Alzheimer's is linked to chronic low-grade inflammation, hyperinsulinemia, and the interplay between peripheral and central insulin resistance, influencing insulin signalling. We evaluated the association between diabetes and Alzheimer's-related neuropathology in cognitively unimpaired older adults with diabetes.

View Article and Find Full Text PDF

Background: Studying brain reserve - the brain's resilience to age-related changes or damage - is crucial for understanding protective mechanisms against cognitive decline. The cerebellum may be a key region in brain reserve, but it has been historically understudied. This investigation delves into this critical area within the largest aging multi-cohort to date.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.

Background: The variability in the regional distribution of Aβ-PET signal and its relation to clinical features is debated. We used data-driven approaches to uncover heterogeneity in cortical Aβ-PET signal from a large representative sample collected through the IDEAS study.

Methods: We analysed cross-sectional Aβ-PET collected from 10,361 patients with MCI or mild dementia scanned in 295 PET facilities using one of the 3 FDA-approved tracers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!